Skip to main content
. 2020 Jan 20;12(1):250. doi: 10.3390/cancers12010250

Table 1.

Combination index (CI): synergism (CI < 1), additive effect (CI = 1) and antagonism (CI > 1).

A. AsPC-1 B. BxPC-3
Erlotinib (µM) CI Erlotinib (µM) CI
0.001 0.43 0.001 0.88
0.01 0.42 0.01 0.84
0.1 0.5 0.1 0.91
1 0.62 1 0.8
10 1.4 10 1.1